You are currently viewing a new version of our website. To view the old version click .

Novel Therapeutic Targets and Approaches, Genetic Markers and Signaling Pathways in Neoplasms

This special issue belongs to the section “Cell and Gene Therapy“.

Special Issue Information

Dear Colleagues,

The study of human neoplastic diseases is a burgeoning and blazing-hot area of biomedicine. However, despite significant advances in this field, some patients are misdiagnosed and, for some, no effective treatments currently available. This Special Issue will provide an overview on the emerging therapeutic targets, approaches and molecular tools as well as novel genetic markers and signaling pathways in neoplasms (benign, malignant and of uncertain or unknown behavior). We welcome pioneering research-based works looking at the subject from a new angle. We also encourage the authors to present their review articles and formulate principally novel views on a subject, as long as their hypothesis and opinions are strongly supported by the body of the previously published experimental data. Research with direct clinical and translational application opening novel curative and diagnostic options is of particular interest.

Dr. Daria A. Chudakova
Dr. Kazuyuki Kitatani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer
  • neoplasms
  • personalized medicine
  • genetic markers
  • next-generation sequencing (NGS)
  • whole-genome sequencing
  • signaling pathways in cancer
  • novel therapeutic targets
  • drug development

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cells - ISSN 2073-4409